title: Generalized granuloma annulare and non-Hodgkin's lymphoma.
authors.forename: Andrea
authors.initials: A
authors.lastname: Bassi
authors.forename: Federica
authors.initials: F
authors.lastname: Scarfi
authors.forename: Massimiliano
authors.initials: M
authors.lastname: Galeone
authors.forename: Meena
authors.initials: M
authors.lastname: Arunachalam
authors.forename: Elisa
authors.initials: E
authors.lastname: Difonzo
mesh_terms: D058846:Antibodies, Monoclonal, Murine-Derived / Q000008:administration & dosage; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage; D001706:Biopsy; D003520:Cyclophosphamide / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D017809:Fatal Outcome; D005260:Female; D016460:Granuloma Annulare / Q000150:complications* / Q000473:pathology; D006801:Humans; D008198:Lymph Nodes / Q000473:pathology; D008228:Lymphoma, Non-Hodgkin / Q000150:complications* / Q000188:drug therapy / Q000473:pathology; D008875:Middle Aged; D011241:Prednisone / Q000008:administration & dosage; D000069283:Rituximab; D012867:Skin / Q000473:pathology; D016896:Treatment Outcome; D014750:Vincristine / Q000008:administration & dosage
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; C571759:R-CHOP protocol; D000069283:Rituximab; D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; D011241:Prednisone